Psoriasis: all 1,928 studies
Page 12 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in PsoriasisStatus unknownNCT04811911Phase 4
- Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted ScoringStatus unknownNCT04809571Not applicable
- Adalimumab Biosimilar in Clinical PracticeCompletedNCT04808739
- Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp PsoriasisCompletedNCT04801433Not applicable
- Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World SettingWithdrawnNCT04799990
- JAK-STAT Signaling Pathway in Pyoderma GangrenosumStatus unknownNCT04792957
- Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of CareActive, not recruitingNCT04780516
- Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis PatientsCompletedNCT04765332
- Comparison of the Frequency of Subclinic Synovitis in the Distal Interphalangeal Joints of the Hand in Psoriasis PatientsCompletedNCT04750993
- The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin DisordersStatus unknownNCT04750161
- Non-pharmacological Mitigation of PsoriasisCompletedNCT04745429Not applicable
- Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)CompletedNCT04744363Phase 1
- Ultraviolet Radiation Forecasting Based Heliotherapy For Psoriasis in Bangkok, ThailandStatus unknownNCT04740983Not applicable
- Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT04728360Phase 3
- Anti-Inflammatory Effects of Time-Restricted FeedingCompletedNCT04728165
- Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis AutoimmunityStatus unknownNCT04722640Phase 4
- Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional StudyStatus unknownNCT04722094
- Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy SubjectsCompletedNCT04711343Phase 1
- Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' NailsCompletedNCT04709354
- Metabolic Biomarkers in Hashimoto's Thyroiditis and PsoriasisActive, not recruitingNCT04693936Not applicable
- Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic PatientsStatus unknownNCT04680624Not applicable
- Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology PatientsCompletedNCT04633616Not applicable
- Risankizumab Long-term Remission StudyCompletedNCT04630652Phase 4
- Brodalumab in Palmoplantar PsoriasisStatus unknownNCT04622033Phase 4
- A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic ArthritisCompletedNCT04614831
- A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque PsoriasisWithdrawnNCT04614298Phase 4
- A Phase 2 Study of Jaktinib in Participants With Moderate to Severe PsoriasisCompletedNCT04612699Phase 2
- A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque PsoriasisCompletedNCT04595409Phase 3
- A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque PsoriasisCompletedNCT04594928Phase 1
- The Diagnostic Ultrasound Enthesitis Tool (DUET) StudyCompletedNCT04587362
- Impact of COVID-19 on Psoriasis PracticeCompletedNCT04581044
- Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic NailsCompletedNCT04580537Phase 2
- A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque PsoriasisCompletedNCT04571567Phase 4
- Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque PsoriasisStatus unknownNCT04571151Phase 4
- Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of PrevalenceStatus unknownNCT04566471
- Pilot Studies Testing Levels of P63 in Psoriasis Skin LesionsCompletedNCT04560647
- The Maintenance Effect of Enstilar Foam in Combination With OtezlaStatus unknownNCT04555707Phase 4
- Efficacy of Roflumilast in the Treatment of PsoriasisCompletedNCT04549870Phase 2
- Development of a Method to Measure mRNA Levels in Skin SamplesCompletedNCT04537468Not applicable
- Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)CompletedNCT04535999Phase 4
- Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)Status unknownNCT04515732Phase 4
- PsoVac: Educational Needs re Vaccines for Biologic Patients With PsoriasisCompletedNCT04513847
- Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on MethotrexateStatus unknownNCT04493762
- An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal UltrasoundWithdrawnNCT04488185Phase 4
- Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory DermatosisCompletedNCT04472546Not applicable
- Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic SyndromeStatus unknownNCT04469829Phase 4
- Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With PsoriasisCompletedNCT04459780Not applicable
- A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in JapanCompletedNCT04459507
- Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT04453137Phase 3
- Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisCompletedNCT04451720Phase 3
- A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) PsoriasisCompletedNCT04439526
- Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic PatientsCompletedNCT04435730
- Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisCompletedNCT04433442
- Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and PsoriasisWithdrawnNCT04423471
- Modified Intermittent Fasting in PsoriasisCompletedNCT04418791Not applicable
- SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasEWithdrawnNCT04417114Phase 4
- Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque PsoriasisStatus unknownNCT04414605Early Phase 1
- Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery SystemCompletedNCT04410237Early Phase 1
- An Explorative Psoriasis Biomarker StudyTerminatedNCT04394936Not applicable
- Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of LifeCompletedNCT04380597
- Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy SubjectsCompletedNCT04371185Phase 1
- Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy SubjectsStatus unknownNCT04367441Phase 1
- How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups?Status unknownNCT04359628
- Serum Level of IL31,33 and 36 in Egyptian Paients With PsoriasisStatus unknownNCT04344574
- Dose Reduction of IL17 and IL23 Inhibitors in PsoriasisCompletedNCT04340076Phase 4
- Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque PsoriasisTerminatedNCT04339595Phase 4
- Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant TherapyStatus unknownNCT04324866
- Work Stress and Impact of Pruritus on Quality of LifeCompletedNCT04316533
- Utility of Squamous Cell Carcinoma Antigen (SCCA) in PsoriasisCompletedNCT04308616
- Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque PsoriasisCompletedNCT04279119Phase 1
- Evaluating of New Screening Tool for Arthritis* in PsoriasisCompletedNCT04277832
- The Anti-inflammatory Effects of Harkány Medicinal WaterStatus unknownNCT04275206Not applicable
- Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis PatientsCompletedNCT04275024Not applicable
- Role of Reverse Transcriptase Inhibitors in the Treatment of PsoriasisCompletedNCT04274595Not applicable
- Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate TherapyCompletedNCT04263610Phase 4
- Efficacy of Low Dose Naltrexone in PsoriasisCompletedNCT04250792Phase 1
- A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp PsoriasisCompletedNCT04243486Phase 2
- Glucose Trnsporter and PEDF in PsoriasisStatus unknownNCT04242082
- Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)CompletedNCT04229836Phase 4
- Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque TestCompletedNCT04221906Phase 1
- Social Media Use of Psoriasis Vulgaris Patients: Multicenter, Survey WorkCompletedNCT04207242
- Use of Alternative Therapy in Psoriasis Vulgaris PatientsCompletedNCT04207216
- A Study of DLX105-DMP in Subjects With Plaque PsoriasisCompletedNCT04203433Phase 1
- Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory DiseasesActive, not recruitingNCT04200690Not applicable
- A Phase 4 Clinical Study of BrodalumabCompletedNCT04183881Phase 4
- A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisCompletedNCT04175613Phase 3
- Clinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT04173637Phase 2
- Anti-Carbamylated Protein Antibodies in Psoriatic ArthritisCompletedNCT04173039Not applicable
- A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT04172233Phase 1/2
- MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic ToolStatus unknownNCT04168619
- A Safety Study of LY3462817 and LY3509754 in Participants With PsoriasisTerminatedNCT04152382Phase 1
- A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent RegimenCompletedNCT04149587
- Ayurvedic Treatment Package in Plaque PsoriasisCompletedNCT04146558Phase 3
- Impact of Decision-Framing in PsoriasisCompletedNCT04136314Not applicable
- A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in AdultsSuspendedNCT04121143Phase 2
- A Study of LY3471851 in Participants With PsoriasisCompletedNCT04119557Phase 1
- Psoriasis、Indigo Naturalis、Chinese Medicine Medicated BathStatus unknownNCT04117919Phase 2
- Psoriatic Arthritis D2P ScreeningActive, not recruitingNCT04110522Not applicable
- A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970CompletedNCT04106297Phase 1
- Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT04102241Phase 2